Volunteering

Volunteering

The role of study volunteers in clinical research is crucial in the advancement of medicine. Without volunteer participation, new ways to prevent, diagnose, and treat diseases cannot be achieved.

We're Here to Answer Your Questions

Our recruitment staff is available Monday through Friday to answer your questions. If you call outside these hours, leave a message, and your call will be returned. If you are interested in a study for healthy volunteers, please call 919-613-6244. If you are interested in a study for a specific medical condition, please call 919-613-6246.

contextual photo

Volunteer Registry

If you are interested in being contacted for future research studies when it appears that you may be eligible based on the information you provide us, join our Research Volunteer Registry.


Additionally, you can view our other study opportunities below.

Asthma Patient Registry

The Duke Early Phase Clinical Research Unit is enrolling people with asthma into the American Lung Association's Asthma Clinical Research Center patient registry. If you have asthma and are interested in becoming involved in ALA-sponsored studies, you may participate in the registry regardless of your smoking status. Registry participants will play a role in furthering medical knowledge about the condition and be notified of any studies they might be qualified to participate in.

For more information

Please contact the Duke Early Phase Clinical Research Unit at 919-684-1554 or dcrurecruit@duke.edu.

Investigational Drug Study for Children or Adults with Pompe Disease

Adults and children who are at least 3 years old are needed to participate in a research study to assess the safety and effectiveness of an investigational drug that is being developed as a potential treatment for Pompe Disease. Eligible participants will be Pompe Disease patients who have not yet been treated with enzyme replacement therapy. Participation will require biweekly infusion visits at the Duke Early Phase Clinical Research Unit for approximately 3 years. Compensation is provided to enrolled participants.

For more information

Please contact study coordinator Wan Lan Liang at 919-668-0972 or wan.liang@duke.edu.

Drug Study for Skin Disease

Volunteers with various types of skin disease are needed to participate in a research study to assess the safety, tolerability, and activity of an investigational drug that is being developed as a potential treatment for plaque psoriasis, palmoplantar pustulosis, or hidradenitis suppurativa. Eligible participants will be men and women who are at least 18 years old and are not currently using a biologic agent to treat their skin disease. Participation involves 15 outpatient visits to the Duke Early Phase Clinical Research Unit over the course of approximately 5 months.

Study volunteers might receive a placebo rather than the active study drug. Compensation is provided to enrolled participants.

For more information

Please contact the Duke Early Phase Clinical Research Unit at 919-613-6244 or dcrurecruit@duke.edu.

Investigational Drug for Traumatic Brain Injury

Healthy volunteers are needed to participate in a research study to assess the safety and tolerability of an investigational drug that is being developed as a potential treatment for brain injury. Eligible participants will be healthy men and women, 18 to 50 years of age, who weigh at least 111 pounds, and use no medications. Participation will require 3 visits to the Duke Early Phase Clinical Research Unit over the course of 4-to-6 weeks. One of these visits will be an inpatient admission that lasts for 8 consecutive nights. Compensation is provided to enrolled participants.

For more information

Please contact the Duke Early Phase Clinical Research Unit at 919-684-1554 or dcrurecruit@duke.edu.